查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1468007

富血小板血漿市場：按來源類型、應用分類 - 2024-2030 年全球預測

Platelet Rich Plasma Market by Source Type (Allogenic, Autologous, Homologous), Application (Cosmetic Surgery, General Surgery, Neurosurgery) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

富血小板血漿市場規模預計2023年為3.8163億美元，2024年達到4.3086億美元，預計2030年將達到8.4854億美元，複合年成長率為12.09%。

富血小板血漿，也稱為PRP，是從富含血小板的全血中獲得的濃縮血漿。 PRP 是透過離心患者的血液樣本來製備的，導致血小板濃度高於基準值。 PRP 的治療用途因其增強身體自然癒合過程的潛力而受到歡迎。 PRP可應用於多種醫學領域，包括整形外科、牙科、運動醫學、創傷治療以及快速發展的美容醫學領域。由於對微創治療的需求增加、運動傷害和整形外科疾病盛行率上升以及尋求美容和抗老化治療的人口老化，對富含血小板的血漿產品和治療的需求正在迅速增加。然而，需要更高品質的隨機對照試驗來證明對各種適應症的療效，且PRP治療的高成本限制了患者對富血小板血漿產品的接受和治療方法的獲取可能受到限制。儘管如此，技術創新正在進行中，以提高 PRP 治療的有效性、安全性和便利性，並有望為 PRP 治療的普及做出貢獻。此外，與學術機構合作產生檢驗應用所需的可靠臨床資料將支持未來幾年 PRP 治療的採用。

主要市場統計
基準年[2023] 3.8163 億美元
預測年份 [2024] 43086萬美元
預測年份 [2030] 84854萬美元
複合年成長率（%） 12.09%

來源類型安全性有利於自體 PRP

同種異體 PRP 是指取自捐贈者而非接受治療的患者的富含血小板的血漿。當患者無法捐贈足夠的血小板或自體 PRP 有副作用風險時，通常會使用自體 PRP。同種異體 PRP 必須經過嚴格的測試，以篩檢病原體並確認與接受者的相容性。關於偏好，當自體 PRP 不可行或有疾病傳播風險時，指定同種異體 PRP。由於自體PRP源自於患者的血液，因此免疫抗原性反應和疾病傳播的風險大大降低。它是最常見的 PRP型態，因為它非常安全。自體 PRP 通常是需要 PRP 治療整形外科損傷或整容手術的患者的首選。同種異體PRP是指以不同於其在體內自然功能的方式使用的富含血小板的血漿，或提供給來源供體以外的個人使用，同時仍遵循相容性的概念。同種異體 PRP 的使用相對不常見且非常特殊。同種異體 PRP 適合適合移植但不適合約種異體和自體 PRP 選項的患者。

PRP 治療在應用整形外科的廣泛應用

富含血小板的血漿廣泛用於整容手術，以促進皮膚再生和癒合。富含血小板的血漿中含有的生長因子濃度可刺激膠原蛋白的產生，可用於拉皮、痤瘡疤痕和脫髮治療等手術。在一般外科手術中，PRP 可以改善創傷治療、管理術後切口並降低感染疾病風險。普通外科手術中基於需求的偏好受到縮短恢復時間和增強癒合能力的潛力的影響。神經外科中的 PRP 用於涉及脊椎和神經組織的手術，以幫助減少發炎並促進康復。神經外科的關鍵性質以及快速有效癒合、最小化疤痕和纖維化的重要性創造了對 PRP 治療的需求。 PRP廣泛應用於整形外科，尤其是肌腱損傷、急性韌帶損傷、肌肉損傷和關節置換術的治療。老化人口中肌肉骨骼疾病的增加正在影響整形外科治療中對 PRP 的需求。

區域洞察

由於對先進醫療保健和運動醫學的重視、尋求肌肉骨骼疾病再生治療的老齡化人口以及尋求快速康復解決方案的運動員集中，美洲的富血小板血漿市場正在迅速開拓。美洲客戶的購買行為青睞創新和微創治療方法。在歐盟（EU），PRP治療的監管地位已經統一，研究活動也不斷增加。強大的醫療基礎設施和客戶對高品質、規範治療的偏好推動了對 PRP 治療的需求。在中東，在尋求高品質醫療服務的富人的支持下，包括 PRP 治療在內的美容醫療市場正在快速成長。相較之下，非洲PRP市場正處於起步階段，主要受到醫療保健設施逐漸改善和治療機會增加的推動。亞太地區正迅速崛起為重要的 PRP 產品市場，其特徵是人口眾多且新興市場開拓迅速。由於可支配收入的增加和醫療旅遊業的增加，新興國家 PRP 療法的採用率顯著增加。在整個亞太地區，客戶的購買模式正在不斷變化，人們越來越重視先進的治療方法，並且越來越願意投資健康和保健。

FPNV定位矩陣

FPNV定位矩陣對於評估富血小板血漿市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對富血小板血漿市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.富血小板血漿市場的市場規模與預測是多少？

2.在富血小板血漿市場預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.富血小板血漿市場的技術趨勢和法規結構是什麼？

4.富血小板血漿市場主要供應商的市場佔有率為何？

5. 進入富血小板血漿市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球與運動相關的傷害呈上升趨勢
      • 在肌肉骨骼和整形外科疾病治療的潛在應用
      • 增加在整容手術和自然癒合過程中的使用
    • 抑制因素
      • 富血小板血漿治療效果的不確定性
    • 機會
      • 再生醫學的新應用
      • 正在進行的富含血小板血漿衍生生物活性分子的研究和開發活動
    • 任務
      • 富血小板血漿產品的臨床試驗和報銷政策有限
  • 市場區隔分析
    • 來源類型：由於安全性，自我 PRP 是首選
    • 應用：PRP 治療在整形外科應用的廣泛應用
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章依來源類型分類的富血小板血漿市場

  • 同種異體的
  • 自體移植
  • 相同的

第7章富血小板血漿市場：依應用分類

  • 整容手術
  • 一般外科
  • 神經外科
  • 整形外科

第8章美洲富血小板血漿市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太富血小板血漿市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲富血小板血漿市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Hairline International推出超音波PRP，最先進的毛髮再生療法
    • Royal Biologics 宣布 BIOINCYTE PRFM 在美國商業上市

第12章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-035AB9C0DA84

[180 Pages Report] The Platelet Rich Plasma Market size was estimated at USD 381.63 million in 2023 and expected to reach USD 430.86 million in 2024, at a CAGR 12.09% to reach USD 848.54 million by 2030.

Platelet-rich plasma, referred to as PRP, is a concentrated form of plasma derived from whole blood rich in platelets. PRP is prepared by centrifuging a sample of the patient's blood, resulting in a platelet concentration above baseline values. The therapeutic use of PRP has gained popularity due to its potential to augment the body's innate healing process. PRP can be applied in various medical fields, including orthopedics, dentistry, sports medicine, wound healing, and the burgeoning field of aesthetic medicine. Increasing demand for minimally invasive treatments, a rise in the prevalence of sports injuries and orthopedic conditions, and an aging population seeking cosmetic and anti-aging treatments have proliferated the need for platelet rich plasma products and treatments. However, the need for more high-quality, randomized controlled trials to prove its efficacy for various indications and the high cost of PRP therapy can limit patient access to platelet rich plasma products and treatments. Nevertheless, the ongoing technological innovations to improve PRP treatments' efficacy, safety, and convenience are expected to contribute to adopting PRP treatments. Moreover, collaborative efforts with academic institutions to produce the robust clinical data necessary to validate applications encourage the adoption of PRP treatments in the coming years.

KEY MARKET STATISTICS
Base Year [2023] USD 381.63 million
Estimated Year [2024] USD 430.86 million
Forecast Year [2030] USD 848.54 million
CAGR (%) 12.09%

Source Type: Preference for Autologous PRP due to its safety profile

Allogenic PRP refers to platelet-rich plasma harvested from a donor rather than the treated patient. Allogenic PRP is often used in cases where the patient is unable to provide a sufficient quantity of platelets or is at risk of adverse reactions from autologous PRP. Allogenic PRP needs to undergo rigorous testing to screen for pathogens and ensure compatibility with the recipient. Regarding preferences, allogenic PRP is specified when autologous PRP is not an option or when there's a risk of disease transmission. Autologous PRP is derived from the patient's blood, significantly reducing the risk of immunogenic reactions or disease transmission. This is the most common form of PRP due to its safety profile. Autologous PRP is typically preferred for patients who require PRP treatments for orthopedic injuries and cosmetic procedures. Homologous PRP refers to platelet-rich plasma that is used differently than its natural function within the body or donated for use in an individual other than the source donor, still following the concept of compatibility. Homologous PRP's usage is relatively less common and highly specific. Homologous PRP is selected for patients whose conditions align with the transplant compatibility and when allogenic and autologous options are less suitable.

Application: Extensive use of PRP treatments in orthopedic applications

Platelet rich plasma is extensively used in cosmetic surgery to promote skin rejuvenation and healing. The concentration of growth factors in platelet rich plasma can stimulate collagen production and be used for procedures such as facelifts, acne scars, and hair loss treatment. In general surgery, PRP can improve wound healing, manage incisions after surgery, and reduce the risk of infections. The need-based preference in general surgery is impacted by the potential for reduced recovery times and enhanced healing capabilities. PRP in neurosurgery finds its use in procedures involving the spine and nerve tissues, which may help reduce inflammation and facilitate recovery. The critical nature of neurosurgical procedures and the paramount importance of quick and effective healing, with minimal scarring or fibrosis, creates the need for PRP treatments. PRP is widely used in orthopedic surgery, particularly in treating tendon injuries, acute ligament, and muscle injuries, as well as for joint arthroplasty. The corresponding rise in musculoskeletal disorders among the aging population influences the need for PRP in orthopedic treatments.

Regional Insights

The platelet rich plasma market in the Americas is rapidly developing owing to a high emphasis on advancing medical procedures and sports medicine, an aging population seeking regenerative treatments for musculoskeletal conditions, and a high concentration of athletes looking for rapid recovery solutions. Customer purchasing behavior in the Americas favors innovative and minimally invasive therapies. The European Union (EU) presents a unified regulatory landscape for PRP therapies, with increasing research activity. The need for PRP treatment is fueled by a robust healthcare infrastructure and customers' preference for high-quality, regulated treatments. The Middle East has a burgeoning market for cosmetic treatments, including PRP therapies, supported by affluent consumers seeking high-end medical services. In contrast, the African PRP market is more nascent, driven primarily by gradually improving healthcare facilities and the increasing accessibility of treatments. Asia-Pacific is rapidly emerging as a significant PRP product market characterized by its large population and developing healthcare sectors. The emerging economies have shown a considerable increase in the adoption of PRP therapies, driven by rising disposable incomes and increasing medical tourism. Across the Asia Pacific, customer purchasing patterns are evolving, shifting towards valuing advanced treatments and a willingness to invest in health and wellness.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Platelet Rich Plasma Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Platelet Rich Plasma Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Platelet Rich Plasma Market, highlighting leading vendors and their innovative profiles. These include APEX Biologix, Arthrex, Inc., Cascade Medical Wellness & Aesthetics, Celling Biosciences, Inc., Crown Laboratories, Inc., Dr PRP USA LLC, EmCyte Corporation, Estar Technologies Ltd., Exactech, Inc., Factor Medical Inc., Fisher Scientific Company L.L.C., Integrity PRP, Isto Biologics, Johnson & Johnson Services, Inc., Juventix Regenerative Medical, LLC, MDBiologix, PRP Concepts, Inc., Regen Lab SA, ROCKY MOUNTAIN BIOLOGICALS, Sarstedt AG & Co. KG, Stryker Corporation, Terumo BCT, Inc., Terumo Corporation, ThermoGenesis Holdings, Inc., Ycellbio Medical Co., Ltd., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Platelet Rich Plasma Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Source Type
    • Allogenic
    • Autologous
    • Homologous
  • Application
    • Cosmetic Surgery
    • General Surgery
    • Neurosurgery
    • Orthopedic Surgery
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Platelet Rich Plasma Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Platelet Rich Plasma Market?

3. What are the technology trends and regulatory frameworks in the Platelet Rich Plasma Market?

4. What is the market share of the leading vendors in the Platelet Rich Plasma Market?

5. Which modes and strategic moves are suitable for entering the Platelet Rich Plasma Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Incidences of Sports-Related Injuries Globally
      • 5.1.1.2. Potential Application in the Treatment of Musculoskeletal Conditions and Orthopedic Disorders
      • 5.1.1.3. Increasing Use in Cosmetic Surgery and for Natural Healing Process
    • 5.1.2. Restraints
      • 5.1.2.1. Uncertainty on Therapeutic Efficacy of Platelet Rich Plasma
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Application in Regenerative Medicine
      • 5.1.3.2. Ongoing Research and Development Activities on Platelet-Rich Plasma Derived Bioactive Molecules
    • 5.1.4. Challenges
      • 5.1.4.1. Limited Availability of Clinical Trials and Reimbursement Policies of Platelet-rich Plasma Products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Source Type: Preference for Autologous PRP due to its safety profile
    • 5.2.2. Application: Extensive use of PRP treatments in orthopedic applications
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Platelet Rich Plasma Market, by Source Type

  • 6.1. Introduction
  • 6.2. Allogenic
  • 6.3. Autologous
  • 6.4. Homologous

7. Platelet Rich Plasma Market, by Application

  • 7.1. Introduction
  • 7.2. Cosmetic Surgery
  • 7.3. General Surgery
  • 7.4. Neurosurgery
  • 7.5. Orthopedic Surgery

8. Americas Platelet Rich Plasma Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Platelet Rich Plasma Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Platelet Rich Plasma Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Hairline International Launches Sonicated PRP- a cutting edge Hair Regeneration Therapy
    • 11.3.2. Royal Biologics Announces U.S. Commercial Launch of BIOINCYTE PRFM

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PLATELET RICH PLASMA MARKET RESEARCH PROCESS
  • FIGURE 2. PLATELET RICH PLASMA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PLATELET RICH PLASMA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PLATELET RICH PLASMA MARKET DYNAMICS
  • FIGURE 7. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PLATELET RICH PLASMA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PLATELET RICH PLASMA MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PLATELET RICH PLASMA MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ALLOGENIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY HOMOLOGOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY HOMOLOGOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY NEUROSURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 32. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 36. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 37. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. CANADA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 40. CANADA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 41. CANADA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. CANADA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 52. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. CHINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. CHINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. CHINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. CHINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. INDIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. INDIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. INDIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. INDIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 113. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. ITALY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. ITALY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. ITALY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. ITALY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. POLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. POLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. POLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. POLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. QATAR PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. QATAR PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. QATAR PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. QATAR PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2023